Kevin H. McKinney, MD
NPI 1770642126ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Galveston, TX
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Galveston, Texas, trained at University of Texas Medical Branch at Galveston (class of 1992). Their prescriptions cost Medicare Part D more than their services did: $1,630,072 for 3,369 claims, against $22,502 paid for services in 2024. Novo Nordisk Inc was the largest of 23 companies reporting payments in 2025, $3,226 in all, mostly food and beverage.
Overview
| NPI | 1770642126 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Dec 8, 2006 |
| Last updated in NPPES | Jul 8, 2007 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | J5182 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 252 |
|---|---|
| Services billed | 447 across 10 procedure codes |
| Paid by Medicare | $22,502 |
Part D prescriptions in 2024
| Prescriptions (claims) | 3,369 · 7,742 30-day fills |
|---|---|
| Patients | 580 |
| Total drug cost | $1,630,072 |
| Generic share | 44% of claims |
Education and affiliations
| Medical school | University of Texas Medical Branch at Galveston |
|---|---|
| Graduation year | 1992 |
| Medicare specialty | Endocrinology |
Medical group
- Utmb Faculty Group PracticeGalveston, TX · 1,101 clinicians
Hospital affiliation
- University of Texas Medical Branch GalvestonGalveston, TX
Industry payments (Open Payments)
- 2025$3,226 · 81 payments from 23 companies
- 2024$3,500 · 94 payments from 22 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $449.53 | 10 |
| Kyowa Kirin, Inc. | $345.03 | 4 |
| Lilly USA, LLC | $313.83 | 6 |
| Amgen Inc. | $237.62 | 7 |
| Madrigal Pharmaceuticals | $228.84 | 4 |
What the 2025 payments were for
- Food and Beverage$3,206 · 80 payments
- Long term medical supply or device loan$19.98 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Galveston
- 1003377417
- 1780875963
- 1568521375
- 1487752804
- 1033278833
- 1982622148
- 1255658340
- 1679197461
- 1487713996
- 1073928016
- 1043877954
- 1053963389
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Texas →